Drug major Lupin today announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations.
Stevens will assume full responsibility for global merger and acquisitions and specialty business strategy, Lupin said in a filing to the BSE.
Prior to joining Lupin, Stevens was with Aptalis pharma as the Chief Corporate Development Officer responsible for M&A, strategy and global business development.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.